4 December 2018

Australia’s first long-acting treatment for opioid dependence now TGA approved

Addiction Drugs TGA


The approval of Buvidal Weekly and Buvidal Monthly will, for the first time, give Australian patients access to a long-acting buprenorphine treatment for opioid dependence [SPONSORED]

To read the rest of this article you need to be a Medical Republic Member and registered with AHPRA, Please login below if you have an account or sign up to join.

Join Now / Login